Third Harmonic Bio Inc (THRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,469 | -30,824 | -35,155 | -29,609 | -12,807 |
| Depreciation Amortization | 49 | 35 | 1 | N/A | N/A |
| Accounts payable and accrued liabilities | 99 | -249 | 290 | 1,216 | 324 |
| Other Working Capital | -893 | 223 | -4,551 | 2,743 | 1,737 |
| Other Operating Activity | 11,711 | 10,390 | 4,498 | 9,904 | 1,559 |
| Operating Cash Flow | $-34,503 | $-20,425 | $-34,917 | $-15,746 | $-9,187 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -169 | -36 | N/A | N/A |
| Investing Cash Flow | $-10 | $-169 | $-36 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 50,506 | 1,264 | 198,285 | N/A | N/A |
| Other Financing Activity | 0 | -465 | -2,294 | 135,749 | 10,825 |
| Financing Cash Flow | $50,506 | $799 | $195,991 | $135,749 | $10,825 |
| Beginning Cash Position | 269,523 | 289,318 | 128,280 | 8,277 | 6,639 |
| End Cash Position | 285,516 | 269,523 | 289,318 | 128,280 | 8,277 |
| Net Cash Flow | $15,993 | $-19,795 | $161,038 | $120,003 | $1,638 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,503 | -20,425 | -34,917 | -15,746 | -9,187 |
| Capital Expenditure | -10 | -169 | -36 | N/A | N/A |
| Free Cash Flow | -34,513 | -20,594 | -34,953 | -15,746 | -9,187 |